Join the Allergic Urticaria group to help and get support from people like you.
Allergic Urticaria News
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 – Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study published online July...
What Are The Best Treatments For Chronic Hives?
FRIDAY, July 18, 2025 — Hives can drive a person crazy, covering parts of the body with maddeningly itchy welts. Now, a new evidence review has identified the most effective treatments for people who ...
Urticaria Reported in Trial of Investigational HIV mRNA Vaccines
MONDAY, May 5, 2025 – Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine. Sharon A. Riddler,...
FDA Approves Dupixent for Chronic Spontaneous Urticaria
WEDNESDAY, April 23, 2025 – The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with chronic spontaneous urticaria. The approval is...
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
TUESDAY, March 11, 2025 – For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's...
FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria
October 11, 2019 - The U.S. Food and Drug Administration (FDA) has approved Quzyttir (cetirizine hydrochloride) injection for the treatment of acute urticaria in adults and children 6 months of age...
FDA Approves Tris Pharma's New Drug Application for Karbinal ER
MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...